Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

398
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
398
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

795
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
795
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

405
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
405
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

916
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
916
Censoring Survival Data01:09

Censoring Survival Data

363
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
363
Wilcoxon Signed-Ranks Test for Median of Single Population01:14

Wilcoxon Signed-Ranks Test for Median of Single Population

314
The Wilcoxon signed-rank test for the median of a single population is a nonparametric test used to evaluate whether the median of a population differs from a specified value. Unlike parametric tests, it does not require data to follow a normal distribution, making it suitable for non-normal or small samples. The test begins by calculating the difference (d) between each observation and the hypothesized median. The absolute values of these differences are ranked in ascending order, with ties...
314

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort.

Neuro-oncology advances·2026
Same author

Assessing the clinical benefit from medical therapies in CNS malignancies: Refining the ESMO Magnitude of Clinical Benefit Scale and the ASCO Value Framework.

Neuro-oncology advances·2025
Same author

Assessing ChatGPT's Educational Potential in Lung Cancer Radiotherapy From Clinician and Patient Perspectives: Content Quality and Readability Analysis.

JMIR cancer·2025
Same author

Reirradiation: Standards, challenges, and patient-focused strategies across tumor types.

CA: a cancer journal for clinicians·2025
Same author

Patient-specific uncertainty calibration of deep learning-based autosegmentation networks for adaptive MRI-guided lung radiotherapy.

Physics in medicine and biology·2025
Same author

Use of radiofrequency electromagnetic fields applied by capacitive hyperthermia for glioblastoma therapy.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·2025

Related Experiment Video

Updated: Nov 21, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K

A Privacy-Preserving Log-Rank Test for the Kaplan-Meier Estimator With Secure Multiparty Computation: Algorithm

Marcel von Maltitz1, Hendrik Ballhausen2,3, David Kaul4,5

  • 1Chair of Network Architectures and Services, Department of Informatics, Technical University of Munich, TUM, Garching, Germany.

JMIR Medical Informatics
|January 18, 2021
PubMed
Summary
This summary is machine-generated.

Secure multiparty computation (SMPC) enables secure multicentric medical research by allowing computation on distributed patient data without sharing it. This privacy-preserving method is feasible for clinical studies.

Keywords:
cryptographydata protectionmulticentric studiesprivacyprivacy preservationsecure multiparty computation

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.4K

Related Experiment Videos

Last Updated: Nov 21, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.4K

Area of Science:

  • Medical Informatics
  • Cryptography
  • Biostatistics

Background:

  • Patient data privacy regulations restrict data sharing for multicentric research.
  • Secure multiparty computation (SMPC) enables secure computation on distributed data without direct exchange.
  • SMPC resolves the conflict between data utilization and data protection in medical research.

Purpose of the Study:

  • To demonstrate the feasibility of secure and privacy-preserving multicentric computation using SMPC with real patient data over the internet.
  • To implement and test a privacy-preserving log-rank test for the Kaplan-Meier estimator.

Main Methods:

  • A secure log-rank test for the Kaplan-Meier estimator was developed using the SPDZ SMPC realization and FRESCO framework.
  • The method was tested with synthetic and real patient data between two university hospitals over the internet.
  • Performance and scaling were evaluated, considering network latency and participant processing power.

Main Results:

  • A functional SMPC-based log-rank evaluation was achieved.
  • Network latency significantly impacts execution time, requiring at least 2 Mbit/s transmission rate.
  • Participant processing power had minimal impact due to parallelization; real-world tests with 100 data items took approximately 20 minutes.

Conclusions:

  • SMPC is applicable and practically feasible for the medical domain.
  • Secure versions of common clinical study evaluation methods can be implemented using current SMPC technology.
  • The approach offers a viable solution for privacy-preserving multicentric medical research.